CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content


Last Updated: September 20, 2006
Result type: Reports
Project Number: SR0075-000
Product Line: Reimbursement Review

Generic Name: Penciclovir

Brand Name: Denavir

Manufacturer: Novartis Consumer Health Care Inc.

Therapeutic Area: Herpes labialis (cold sores)

Indications: Herpes labialis (cold sores)

Submission Type: Initial

Project Status: Complete

Date Recommendation Issued: April 26, 2007

Recommendation Type: Do not list